Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
xiao'er houerhuan xiaoyan granules
- Development stage
- Unknown
- Lead developer
- Jiangxi Xinglin Baima Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xiao'er Houerhuan Xiaoyan granules is a Traditional Chinese Medicine (TCM) developed by Jiangxi Xinglin Baima Pharmaceutical Co., Ltd. for the treatment of pediatric acute upper respiratory tract infections. The formulation is based on the extract of the medicinal plant *Pithecellobium clypearia* (known as Houerhuan in Chinese), which is traditionally recognized for its heat-clearing, detoxifying, and anti-inflammatory properties. It is specifically indicated for children presenting with the "wind-heat" pattern of the common cold, targeting symptoms such as fever, sore throat, and cough. The drug is currently being evaluated in Phase II clinical trials in China to determine the optimal safe dose and preliminary efficacy in the pediatric population.
- Other names
- Xiao'er Hou'Er Huan Xiaoyan granulesXiao'er Houerhuan Xiaoyan Keli小儿猴耳环消炎颗粒
Beyond the preview
Go deeper on xiao'er houerhuan xiaoyan granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on xiao'er houerhuan xiaoyan granules.